Anti-inflammatory and anti-fibrotic treatment in a rodent model of acute lung injury induced by sulfur dioxide

References

• Wang XB, Du JB, Cui H. Sulfur dioxide, a double-faced molecule in mammals. Life Sci. 2014;98:63–67.
   PubMed Web of Science ®Google Scholar
• Meng Z, Qin G, Zhang B, et al. Oxidative damage of sulfur dioxide inhalation on lungs and hearts of mice. Environ Res. 2003;93:285–292.
   PubMed Web of Science ®Google Scholar
• Meng Z. Oxidative damage of sulfur dioxide on various organs of mice: sulfur dioxide is a systemic oxidative damage agent. Inhal Toxicol. 2003;15:181–195.
   PubMed Web of Science ®Google Scholar
• Woodford DM, Coutu RE, Gaensler EA. Obstructive lung disease from acute sulfur dioxide exposure. Respiration 1979;38:238–245.
   PubMed Web of Science ®Google Scholar
• Charan NB, Myers CG, Lakshminarayan S, et al. Pulmonary injuries associated with acute sulfur dioxide inhalation. Am Rev Respir Dis. 1979;119:555–560.
   PubMed Web of Science ®Google Scholar
• Cohen HJ, Drew RT, Johnson JL, et al. Molecular basis of the biological function of molybdenum: the relationship between sulfite oxidase and the acute toxicity of bisulfite and SO2. Proc Natl Acad Sci USA 1973;70:3655–3659.
   PubMed Web of Science ®Google Scholar
• Stratmann U, Lehmann RR, Steinbach T, et al. Effect of sulfur dioxide inhalation on the respiratory tract of the rat. Zentralbl Hyg Umweltmed. 1991;192:324–335.
   PubMedGoogle Scholar
• Meng Z, Geng H, Bai J, et al. Blood pressure of rats lowered by sulfur dioxide and its derivatives. Inhal Toxicol. 2003;15:951–959.
   PubMed Web of Science ®Google Scholar
• Rabinovitch S, Greyson ND, Weiser W, et al. Clinical and laboratory features of acute sulfur dioxide inhalation poisoning: two-year follow-up. Am Rev Respir Dis. 1989;139:556–558.
   PubMedGoogle Scholar
• Atkinson DA, Sim TC, Grant JA. Sodium metabisulfite and SO2 release: an under-recognized hazard among shrimp fishermen. Ann Allergy. 1993;71:563–566.
   PubMedGoogle Scholar
• Harkonen H, Nordman H, Korhonen O, et al. Long-term effects of exposure to sulfur dioxide. Lung function four years after a pyrite dust explosion. Am Rev Respir Dis. 1983;128:890–893.
   PubMed Web of Science ®Google Scholar
• Huber AL, Loving TJ. Fatal asthma attack after inhaling sulfur fumes. JAMA 1991;266:2225
   PubMed Web of Science ®Google Scholar
• Skalpe IO. Long-term effects of sulphur dioxide exposure in pulp mills. Br J Ind Med. 1964;21:69–73.
   PubMedGoogle Scholar
• Brooks SM, Weiss MA, Bernstein IL. Reactive airways dysfunction syndrome (RADS). Persistent asthma syndrome after high level irritant exposures. Chest. 1985;88:376–384.
   PubMed Web of Science ®Google Scholar
• Wigenstam E, Elfsmark L, Bucht A, et al. Inhaled sulfur dioxide causes pulmonary and systemic inflammation leading to fibrotic respiratory disease in a rat model of chemical-induced lung injury. Toxicology 2016;368–369:28–36.
   PubMed Web of Science ®Google Scholar
• Dinis-Oliveira RJ, Duarte JA, Remiao F, et al. Single high dose dexamethasone treatment decreases the pathological score and increases the survival rate of paraquat-intoxicated rats. Toxicology 2006;227:73–85.
   PubMed Web of Science ®Google Scholar
• Wang J, Zhang L, Walther SM. Inhaled budesonide in experimental chlorine gas lung injury: influence of time interval between injury and treatment. Intensive Care Med. 2002;28:352–357.
   PubMed Web of Science ®Google Scholar
• Jonasson S, Wigenstam E, Koch B, et al. Early treatment of chlorine-induced airway hyperresponsiveness and inflammation with corticosteroids. Toxicol Appl Pharmacol. 2013;271:168–174.
   PubMed Web of Science ®Google Scholar
• Wigenstam E, Jonasson S, Koch B, et al. Corticosteroid treatment inhibits airway hyperresponsiveness and lung injury in a murine model of chemical-induced airway inflammation. Toxicology 2012;301:66–71.
   PubMed Web of Science ®Google Scholar
• Wigenstam E, Koch B, Bucht A, et al. N-acetyl cysteine improves the effects of corticosteroids in a mouse model of chlorine-induced acute lung injury. Toxicology. 2015;328:40–47.
   PubMed Web of Science ®Google Scholar
• Luo S, Pauluhn J, Trubel H, et al. Corticosteroids found ineffective for phosgene-induced acute lung injury in rats. Toxicol Lett. 2014;229:85–92.
   PubMed Web of Science ®Google Scholar
• Wigenstam E, Elfsmark L, Koch B, et al. Acute respiratory changes and pulmonary inflammation involving a pathway of TGF-beta1 induction in a rat model of chlorine-induced lung injury. Toxicol Appl Pharmacol. 2016;309:44–54.
   PubMed Web of Science ®Google Scholar
• Seifirad S, Keshavarz A, Taslimi S, et al. Effect of pirfenidone on pulmonary fibrosis due to paraquat poisoning in rats. Clin Toxicol. 2012;50:754–758.
   PubMed Web of Science ®Google Scholar
• Gustafsson A, Jonasson S, Sandstrom T, et al. Genetic variation influences immune responses in sensitive rats following exposure to TiO2 nanoparticles. Toxicology. 2014;326:74–85.
   PubMed Web of Science ®Google Scholar
• Bjornham O, Grahn H, von Schoenberg P, et al. The 2016 Al-Mishraq sulphur plant fire: source and health risk area estimation. Atmos Environ. 2017;169:287–296.
   Web of Science ®Google Scholar
• Butt Y, Kurdowska A, Allen TC. Acute lung injury: a clinical and molecular review. Arch Pathol Lab Med. 2016;140:345–350.
   PubMed Web of Science ®Google Scholar
• Herfs M, Hubert P, Poirrier AL, et al. Proinflammatory cytokines induce bronchial hyperplasia and squamous metaplasia in smokers: implications for chronic obstructive pulmonary disease therapy. Am J Respir Cell Mol Biol. 2012;47:67–79.
   PubMed Web of Science ®Google Scholar
• Liu F, Pauluhn J, Trubel H, et al. Single high-dose dexamethasone and sodium salicylate failed to attenuate phosgene-induced acute lung injury in rats. Toxicology. 2014;315:17–23.
   PubMed Web of Science ®Google Scholar
• de Lange DW, Meulenbelt J. Do corticosteroids have a role in preventing or reducing acute toxic lung injury caused by inhalation of chemical agents?. Clin Toxicol. 2011;49:61–71.
   PubMed Web of Science ®Google Scholar
• Knuppel L, Ishikawa Y, Aichler M, et al. A novel antifibrotic mechanism of nintedanib and pirfenidone. Inhibition of collagen fibril assembly. Am J Respir Cell Mol Biol. 2017;57:77–90.
   PubMed Web of Science ®Google Scholar
• Lopez-de la Mora DA, Sanchez-Roque C, Montoya-Buelna M, et al. Role and new insights of pirfenidone in fibrotic diseases. Int J Med Sci. 2015;12:840–847.
   PubMed Web of Science ®Google Scholar
• Fujimoto H, Kobayashi T, Azuma A. Idiopathic pulmonary fibrosis: treatment and prognosis. Clin Med Insights Circ Respir Pulm Med. 2015;9:179–185.
   PubMed Web of Science ®Google Scholar
• Günther A, Korfei M, Mahavadi P, et al. Unravelling the progressive pathophysiology of idiopathic pulmonary fibrosis. Eur Respir Rev. 2012;21:152–160.
   PubMedGoogle Scholar
• Schaefer CJ, Ruhrmund DW, Pan L, et al. Antifibrotic activities of pirfenidone in animal models. Eur Respir Rev. 2011;20:85–97.
   PubMedGoogle Scholar
• Yu W, Guo F, Song X. Effects and mechanisms of pirfenidone, prednisone and acetylcysteine on pulmonary fibrosis in rat idiopathic pulmonary fibrosis models. Pharm Biol. 2017;55:450–455.
   PubMed Web of Science ®Google Scholar
• Robalo-Cordeiro C, Campos P, Carvalho L, et al. Idiopathic pulmonary fibrosis in the era of antifibrotic therapy: searching for new opportunities grounded in evidence. Rev Port Pneumol (2006). 2017;23:287–293.
   PubMed Web of Science ®Google Scholar
• Ma J, Sun F, Chen B, et al. Tissue metabolic changes for effects of pirfenidone in rats of acute paraquat poisoning by GC-MS. Toxicol Ind Health. 2017;33:887–900.
   PubMed Web of Science ®Google Scholar
• Mansoor JK, Decile KC, Giri SN, et al. Influence of pirfenidone on airway hyperresponsiveness and inflammation in a Brown-Norway rat model of asthma. Pulm Pharmacol Ther. 2007;20:660–668.
   PubMed Web of Science ®Google Scholar
• Hirano A, Kanehiro A, Ono K, et al. Pirfenidone modulates airway responsiveness, inflammation, and remodeling after repeated challenge. Am J Respir Cell Mol Biol. 2006;35:366–377.
   PubMed Web of Science ®Google Scholar
• Matthay MA, Zemans RL. The acute respiratory distress syndrome: pathogenesis and treatment. Annu Rev Pathol. 2011;6:147–163.
   PubMed Web of Science ®Google Scholar
• Sakamoto S, Muramatsu Y, Satoh K, et al. Effectiveness of combined therapy with pirfenidone and inhaled N-acetylcysteine for advanced idiopathic pulmonary fibrosis: a case-control study. Respirology. 2015;20:445–452.
   PubMed Web of Science ®Google Scholar
• Tanaka K, Azuma A, Miyazaki Y, et al. Effects of lecithinized superoxide dismutase and/or pirfenidone against bleomycin-induced pulmonary fibrosis. Chest. 2012;142:1011–1019.
   PubMed Web of Science ®Google Scholar
• Raghu G, Anstrom KJ, King TE, Jr, et al. Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis. N Engl J Med. 2012;366:1968–1977.
   PubMed Web of Science ®Google Scholar
• Rocksen D, Lilliehook B, Larsson R, et al. Differential anti-inflammatory and anti-oxidative effects of dexamethasone and N-acetylcysteine in endotoxin-induced lung inflammation. Clin Exp Immunol. 2000;122:249–256.
   PubMed Web of Science ®Google Scholar
• Hemström P, Larsson A, Elfsmark L, et al. L-alpha-phosphatidylglycerol chlorohydrins as potential biomarkers for chlorine gas exposure. Anal Chem. 2016;88:9972–9979.
   PubMed Web of Science ®Google Scholar
• Elfsmark L, Ågren L, Akfur C, et al. 8-Isoprostane is an early biomarker for oxidative stress in chlorine-induced acute lung injury. Toxicol Lett. 2018;282:1–7.
   PubMed Web of Science ®Google Scholar